You are here: Home » PTI Stories » National » News
Business Standard

Strides Shasun arm gets USFDA nod for allergy relief drug

Press Trust of India  |  New Delhi 

today said its wholly-owned subsidiary has received approval from the US health regulator for Hydrochloride tablets, used to relieve symptoms.

In a filing, it said Global Pte. has received approval from the Food and Drug Administration (USFDA) for Hydrochloride tablets USP, 4mg.

The approved product is a generic version of tablets of Merck & Co. Inc.

Strides said the product will be manufactured at its oral dosage facility at Bengaluru and will be marketed by Inc in the US.

Citing IQVIA data, the company said the US market for Hydrochloride tablets USP, 4 mg is approximately USD 20 million.

tablets is an used to relieve symptoms such as watery eyes, runny nose, sneezing, hives, and itching.

The company's stock was trading 0.58 per cent higher at Rs 645.60 per scrip on the

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, April 12 2018. 12:30 IST